CSIMarket
 


Merck and Co Inc   (MRK)
Other Ticker:  
 
 

MRK's Income from Cont. Operations Growth by Quarter and Year

Merck And Co Inc 's Income from Cont. Operations results by quarter and year




MRK Income from Cont. Operations (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December -2,092.00 2,364.00 1,778.00 -1,038.00
III Quarter September 2,945.00 1,907.00 1,958.00 -51.00
II Quarter June 3,010.00 2,644.00 1,716.00 1,951.00
I Quarter March 3,219.00 2,862.00 741.00 1,556.00
FY   7,082.00 9,777.00 6,193.00 2,418.00



MRK Income from Cont. Operations forth quarter 2020 Y/Y Growth Comment
Merck and Co Inc in the forth quarter recorded loss from continued operations of $ -2,092.00 millions.

Looking into forth quarter results within Major Pharmaceutical Preparations industry 17 other companies have achieved higher Income from Cont. Operations growth. While Merck And Co Inc ' s Income from Cont. Operations no change of % ranks overall at the positon no. 920 in the forth quarter.




MRK Income from Cont. Operations ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - 32.96 % - -
III Quarter September 54.43 % -2.6 % - -
II Quarter June 13.84 % 54.08 % -12.05 % 61.37 %
I Quarter March 12.47 % 286.23 % -52.38 % 37.7 %
FY   -27.56 % 57.87 % 156.12 % -38.65 %

Financial Statements
Merck And Co Inc 's forth quarter 2020 Income from Cont. Operations $ -2,092.00 millions MRK's Income Statement
Merck And Co Inc 's forth quarter 2019 Income from Cont. Operations $ 2,364.00 millions Quarterly MRK's Income Statement
New: More MRK's historic Income from Cont. Operations Growth >>


MRK Income from Cont. Operations (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - 23.96 % -9.19 % -
III Quarter September -2.16 % -27.87 % 14.1 % -
II Quarter June -6.49 % -7.62 % 131.58 % 25.39 %
I Quarter March 36.17 % 60.97 % - -
FY (Year on Year)   -27.56 % 57.87 % 156.12 % -38.65 %




Income from Cont. Operations forth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #18
Healthcare Sector #79
Overall #920

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
575.58 % 39.25 % -92.46 %
(Jun 30 2019)   (Dec. 30, 2010)
Income from Cont. Operations forth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #18
Healthcare Sector #79
Overall #920
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
575.58 % 39.25 % -92.46 %
(Jun 30 2019)   (Dec. 30, 2010)

Income from Cont. Operations by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Merck And Co Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MRK's IV. Quarter Q/Q Income from Cont. Operations Comment
IV. Quarter 2020 loss from continued operations of -2,092.00 millions by Merck and Co Inc appear even worse if you take a look at loss from continued operations 2,945.00 millions in the third quarter.

Within Major Pharmaceutical Preparations industry Merck and Co Inc achieved highest sequential Income from Cont. Operations growth. While Merck And Co Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MRK's IV. Quarter Q/Q Income from Cont. Operations Comment
Recent loss from continued operations of -2,092.00 millions by Merck and Co Inc come out even worse if you take a look at 2,945.00 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Merck and Co Inc achieved highest sequential Income from Cont. Operations growth. While Merck And Co Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Merck And Co Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
Cumulative Income from Cont. Operations 12 Months Ending $ 7,082.00 $ 11,538.00 $ 10,500.00 $ 10,134.00 $ 9,777.00
Y / Y Income from Cont. Operations Growth (TTM) -27.56 % 25.54 % 13.61 % 21.89 % 57.87 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 983 # 520 # 305 # 267 # 179
Seqeuential Income from Cont. Operations Change (TTM) -38.62 % 9.89 % 3.61 % 3.65 % 6.38 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 1270 # 700 # 676 # 341 # 394




Cumulative Income from Cont. Operations growth Comment
For the 12 months ended Dec 31 2020 Merck And Co Inc reported a drop in Income from Cont. Operations by -27.56% year on year, to $7,082 millions, compare to the 25.54% growth at Sep 30 2020.

In the Healthcare sector 81 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 520 to 983.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
146.86 %
7.07 %
-87.73 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 27
Healthcare Sector # 82
Overall # 983

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
575.58 %
39.25 %
-92.46 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 27
Sector # 112
S&P 500 # 1270
Cumulative Income from Cont. Operations growth Comment
For the 12 months ended Dec 31 2020 Merck And Co Inc reported a drop in Income from Cont. Operations by -27.56% year on year, to $7,082 millions, compare to the 25.54% growth at Sep 30 2020.

In the Healthcare sector 81 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 520 to 983.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
146.86 %
7.07 %
-87.73 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 27
Healthcare Sector # 82
Overall # 983

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
575.58 %
39.25 %
-92.46 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 27
Sector # 112
S&P 500 # 1270




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
MRK's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for MRK's Competitors
Income from Cont. Operations Growth for Merck And Co Inc 's Suppliers
Income from Cont. Operations Growth for MRK's Customers

You may also want to know
MRK's Annual Growth Rates MRK's Profitability Ratios MRK's Asset Turnover Ratio MRK's Dividend Growth
MRK's Roe MRK's Valuation Ratios MRK's Financial Strength Ratios MRK's Dividend Payout Ratio
MRK's Roa MRK's Inventory Turnover Ratio MRK's Growth Rates MRK's Dividend Comparisons



Companies with similar Income from Cont. Operations drop for the quarter ending Dec 31 2020 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Dec 31 2020
Fresenius Medical Care Ag and Co Kgaa-0.19%$ -0.185 millions
Sensus Healthcare Inc -1.99%$ -1.991 millions
Xeris Pharmaceuticals Inc -2.78%$ -2.784 millions
Dr Reddys Laboratories Ltd-4.78%$ -4.779 millions
Amgen Inc -5.17%$ -5.167 millions
National Research Corporation-5.59%$ -5.587 millions
Fonar Corp-6.68%$ -6.676 millions
Zoetis Inc -6.77%$ -6.771 millions
Supernus Pharmaceuticals inc -7.13%$ -7.127 millions
Abiomed Inc -10.62%$ -10.617 millions
Lifevantage Corp-11.41%$ -11.411 millions
Icon Plc-11.41%$ -11.412 millions
Corcept Therapeutics Inc-11.53%$ -11.528 millions
Taro Pharmaceutical Industries Ltd-13.32%$ -13.318 millions
Radnet Inc -13.37%$ -13.369 millions
Davita Inc -15.43%$ -15.426 millions
Stryker Corp-21.66%$ -21.655 millions
Utah Medical Products Inc-21.71%$ -21.707 millions
Kamada Ltd-22.97%$ -22.970 millions
Teleflex Incorporated-28.93%$ -28.934 millions
Amarin Corp Plcuk-30.31%$ -30.306 millions
Novartis Ag-31.23%$ -31.235 millions
Pra Health Sciences Inc -31.48%$ -31.476 millions
Springworks Therapeutics Inc -33.04%$ -33.036 millions
Pacific Health Care Organization Inc-35.40%$ -35.397 millions
Concert Pharmaceuticals Inc -37.70%$ -37.699 millions
Zynex Inc-39.36%$ -39.362 millions
Alexion Pharmaceuticals Inc -39.73%$ -39.730 millions
Gilead Sciences Inc -42.58%$ -42.581 millions
China Health Industries Holdings Inc -42.80%$ -42.797 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CMS's Profile

Stock Price

CMS's Financials

Business Description

Fundamentals

Charts & Quotes

CMS's News

Suppliers

CMS's Competitors

Customers & Markets

Economic Indicators

CMS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071